About this course
The majority of the world’s estimated 250 million chronic hepatitis B virus (HBV) carriers live in Asia. The Asian health care provider’s role in the prevention, screening, and monitoring of patients with hepatitis B is crucial for timely diagnosis and linkage to ongoing specialist care.
Learning outcomes
At the end of this module, learners will be able to:
- Identify the common symptoms of HBV
- Accurately diagnose HBV
- Prescribe the preferred treatments for HBV
Topics covered
- Prevention via hepatitis B vaccination, screening, and regular follow-up
- Important diagnostic challenges
- Guideline-based therapy with tenofovir alafenamide, tenofovir disoproxil fumarate, entecavir, and peginterferon
- Considerations for selecting optimum treatment
1 CME Point Available
- This module is accredited for 1 CME Point for medical practitioners enrolled in The Medical Council of Hong Kong’s Continuing Medical Education Programme for Practising Doctors who are not taking CME for Specialists.
- This module is accredited for 1 CME Point for fellows of the Hong Kong College of Physicians.
- Please note that this module will not earn CME credit for fellows of colleges not listed here.
- A certificate can be downloaded upon successful completion. Please use the information on the certificate to claim your CME points.
Reviewed and endorsed by